顽固性复视的发病率、危险因素与管理
该研究通过英国眼科监测单元开展为期1年的前瞻性观察研究,确定顽固性复视的年发病率为53例,最常见前驱事件为斜视手术(32%),斜视手术后的发病率为1/494(95%CI 1/296至790),总体治疗成功率低,不透明人工晶状体(86%)和不透明接触镜(50%)最有效。
要点
- 顽固性复视年发病率为53例,最常见前驱事件为斜视手术(32%)和自发性(25%)。
- 7岁及以上风险人群中,斜视手术后顽固性复视发病率为1/494(95%CI 1/296至790)。
- 不透明人工晶状体成功率86%,不透明接触镜成功率50%,总体成功率低。
核心结论
- 顽固性复视相对罕见但重要,主要危险因素为既存斜视,对无明确双眼视功能者计划手术矫正时需仔细咨询。
- 使用不透明人工晶状体时治疗成功率高但伴随额外风险,其他方法常令人失望且难以成功消除复视。
研究设计与样本
- 通过英国眼科监测单元(BOSU)开展为期1年的前瞻性观察研究,实施报告机制并发放事件问卷和6个月后随访问卷。
主要发现
- 顽固性复视年发病率为53例。
- 最常见前驱事件为斜视手术(32%)、无已知前驱事件即自发性(25%)、严重头部外伤(8%)、白内障手术(6%)和玻璃体切除术(6%)。
- 7岁及以上风险人群中,斜视手术后顽固性复视发病率为1/494(95%CI 1/296至790)。
- 管理中共使用9种不同治疗,许多患者接受2至4种不同方法,总体成功率低。
- 不透明人工晶状体成功率86%,不透明接触镜成功率50%。
关键数值与推荐
- 顽固性复视年发病率为53例。
- 斜视手术后顽固性复视在7岁及以上风险人群中发病率为1/494(95%CI 1/296至790)。
- 不透明人工晶状体成功率86%,不透明接触镜成功率50%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: There is a paucity of literature concerning intractable diplopia. The aims of this study were to determine the incidence of intractable diplopia in the UK, identify the causes and any associated risk factors, establish how cases are managed and if the treatment is successful and tolerated. METHODS: A 1-year prospective observational study was undertaken via the British Ophthalmological Surveillance Unit (BOSU). This involved implementation of a reporting mechanism, which then triggered distribution of an incident questionnaire to explore clinical details concerning each case and a follow-up questionnaire 6 months later to explore how the case had been managed. RESULTS: The incidence of intractable diplopia was 53 cases per year. The most common preceding events were strabismus surgery (32%), no known preceding event, that is,spontaneous (25%), severe head trauma (8%), cataract surgery (6%) and vitrectomy (6%). In the at-risk age group of 7 years and above, the incidence of intractable diplopia following strabismus surgery is 1 in 494 (95% CI; 1 in 296 to 790) cases. A total of nine different treatments were used in the management, with many patients receiving between two and four different methods. The overall success rate was poor, but most effective were opaque intraocular lenses (IOLs) (86%) and opaque contact lenses (50%). CONCLUSION: Intractable diplopia is a relatively rare but important condition. The main risk factor is a pre-existing strabismus, and careful counselling is needed when planning surgical correction in patients with no demonstrable binocular function. Treatment success of intractable diplopia is high when using opaque IOLs, although with additional risk, but is often disappointing via other methods where it can be difficult to eradicate the diplopia successfully.
引用
- Newsham D, O'Connor AR, Harrad RA, et al. Incidence, risk factors and management of intractable diplopia. Br J Ophthalmol. 2017. PMID: 28659388. doi:10.1136/bjophthalmol-2017-310454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。